Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective.
暂无分享,去创建一个
D. Hawkins | C. Rodríguez-Galindo | M. Chintagumpala | T. Laetsch | R. Gartrell | J. Kamihara | Kenneth S. Chen | Brittani K N Seynnaeve | K. Schultz | A. O'Neill | J. Berry | R. Shah | Emily Christison-Lagay | Samara L Potter | Sarah G. Mitchell | J. Rosenblum | J. Piao | Lauren M. Vasta | Ashley Flynn | Farzana Pashnakar | R. Shah | B. Seynnaeve
[1] A. Rangaswami,et al. Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry , 2022, Cancer.
[2] A. Heinzel,et al. The effect of surveillance for differentiated thyroid carcinoma in childhood cancer survivors on survival rates: a decision-tree-based analysis , 2022, Endocrine connections.
[3] David B. Wilson,et al. Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/DICER1 Registry , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] T. Merchant,et al. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321) , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] I. Yeh,et al. Spitz melanocytic tumours – a review , 2021, Histopathology.
[6] C. Weldon,et al. Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] P. Vlcek,et al. RET, NTRK, ALK, BRAF and MET fusions in a large cohort of pediatric papillary thyroid carcinomas. , 2020, Thyroid : official journal of the American Thyroid Association.
[8] M. Fassnacht,et al. Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib. , 2020, The Journal of clinical endocrinology and metabolism.
[9] M. Berger,et al. PD-1 Blockade in Advanced Adrenocortical Carcinoma. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] A. Pappo,et al. Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. O'Brien,et al. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Z. J. Qian,et al. Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973-2013. , 2019, JAMA otolaryngology-- head & neck surgery.
[13] Jessica L. Davis,et al. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. , 2018, The Lancet. Oncology.
[14] Gretchen M. Williams,et al. DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies , 2018, Clinical Cancer Research.
[15] M A Weinstock,et al. Epidemiology of melanoma. , 2017, Cancer treatment and research.
[16] W. Foulkes,et al. Retinoblastoma and Neuroblastoma Predisposition and Surveillance , 2017, Clinical Cancer Research.
[17] L. Strong,et al. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome , 2017, Clinical Cancer Research.
[18] E. Beierle,et al. Colorectal carcinoma in pediatric patients: A comparison with adult tumors, treatment and outcomes from the National Cancer Database. , 2016, Journal of pediatric surgery.
[19] F. Mottaghy,et al. Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents – Recommendations of the GPOH-NPC Study Group , 2016, Klinische Pädiatrie.
[20] K. Harms,et al. Atypical Spitz Tumors: A Diagnostic Challenge. , 2015, Archives of pathology & laboratory medicine.
[21] M. Luster,et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. , 2015, Thyroid : official journal of the American Thyroid Association.
[22] Claudia Eichler-Jonsson,et al. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] J. Cormier,et al. Melanoma incidence rises for children and adolescents: an epidemiologic review of pediatric melanoma in the United States. , 2013, Journal of pediatric surgery.
[24] I. Zalaudek,et al. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview. , 2013, Dermatologia clinica.
[25] Jenine K. Harris,et al. Incidence of Childhood and Adolescent Melanoma in the United States: 1973–2009 , 2013, Pediatrics.
[26] H. Christiansen,et al. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults , 2012, Cancer.
[27] A. Pappo,et al. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Ross,et al. Trends in childhood cancer incidence in the U.S. (1992–2004) , 2008, Cancer.
[29] C. Rodríguez-Galindo,et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] D. Evans,et al. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors. , 1999, American journal of human genetics.
[31] C. Portwine,et al. High frequency of germline p53 mutations in childhood adrenocortical cancer. , 1994, Journal of the National Cancer Institute.
[32] R. Lloyd,et al. Correlation of pathologic features with clinical outcome in pediatric adrenocortical neoplasia. A study of a Brazilian population. Brazilian Group for Treatment of Childhood Adrenocortical Tumors. , 1994, American journal of clinical pathology.
[33] M. Wooten,et al. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature , 1993, Cancer.